+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Search Bar & Filters

Found 3 Actively Recruiting clinical trials

A

Actively Recruiting

Researchers are evaluating the safety and performance of Abbotts commercially available Structural Heart SH devices in real-world hospital settings. This observational registry collects data to meet regulatory requirements, such as the European Union Medical Device Regulations 2017745, by actively monitoring these devices after market approval. The study includes patients undergoing standard care procedures involving Abbott SH devices, with a focus on confirming device safety and performance across multiple device types. Participants receive one or more Abbott SH devices during routine hospital procedures, including Amplatzer Occlusion Devices for septal defects and Epic Surgical Tissue Heart Valve devices for heart valve replacement. The registry enrolls patients either before the procedure or shortly after, depending on the device type, with follow-up visits aligned with standard care schedules. Follow-up may include discharge or 7-day post-procedure visits, short-term 1-3 months, mid-term 6 months, and long-term up to 12 months or even 10 years assessments depending on the device used. A specific surgical valve sub-study collects additional data for certain valve sizes to support regulatory approval in the US. Participants are monitored through their routine care visits, which may occur in person, by phone, or virtually. Data collected include safety and effectiveness outcomes at various time points post-procedure. The registry plans to enroll approximately 500 subjects annually across about 25 global sites, with follow-up duration varying by device type to cover short- and long-term safety and performance. The total study completion is expected by November 2039, allowing extended monitoring of patient outcomes.

All AgesAll Genders
36 locations
M

Actively Recruiting

This registry is designed to support ongoing post-market surveillance for surgical heart valve repair and replacement products used in patients with heart valve disease. It aims to monitor long-term device performance and safety in a real-world setting over an extended period. Participants include patients who have received or are intended to receive surgical heart valve repair or replacement devices. The registry collects information on these devices without assigning treatments, focusing on observing their effects and any adverse outcomes over time. During the study, participants health and device status will be monitored through follow-up assessments. Researchers will track unique device failure modes and trends in adverse effects related to the devices for up to 10 years. Participation duration may vary, with continued data collection to inform device safety and performance.

All AgesAll Genders
26 locations
E

Actively Recruiting

Spontaneous coronary artery dissection SCAD is a recognized cause of non-atherosclerotic acute coronary syndromes, mainly affecting young women without typical risk factors. Researchers are building the first pan-European SCAD registry to improve understanding of this conditions diagnosis and management, inform guidelines, educate clinicians, and promote research. This international, multicenter, observational study includes both retrospective and prospective patient data. The study collects data without any treatment interventions, enrolling at least 500 new patients and 500 historical cases from about 30 countries and 120 sites. Patient information is gathered from their first SCAD event, at enrollment, and then yearly for up to five years or until study completion. There are no study drugs or procedures involved as it is purely observational. Participants will provide data at multiple time points including baseline and yearly follow-ups for up to five years. Researchers will review patient status, vital signs, recurrent SCAD events, imaging results, medications, menstrual and obstetric history, and discharge details. Additional information on procedures, other coronary events, symptoms, pregnancy and hormonal therapy, exercise habits, mental health, and employment after SCAD will also be collected. This allows a comprehensive understanding of SCAD over time.

Age: 18Years +All Genders
73 locations